Implementation of circulating cell-free DNA screening for fetal aneuploidies
Circulating cell-free DNA (cfDNA) consists of extracellular DNA fragments that circulate in the bloodstream and derived from apoptotic cells such as hematopoietic cells or placental trophoblast cells during pregnancy.
Saved in:
| Main Authors: | Madrigal Bajo Irene, Jodar Bifet Meritxell, Badenas Orquin Celia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-03-01
|
| Series: | Advances in Laboratory Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/almed-2025-0055 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Implementación del ADN libre circulante para la detección de aneuploidías fetales
by: Madrigal Bajo Irene, et al.
Published: (2025-02-01) -
NIPT of Maternal Plasma-Originated cfDNA: Applications and Guide for the Implementation
by: Fernández Martínez FJ, et al.
Published: (2025-04-01) -
The evolution of cell-free fetal DNA testing: expanded non-invasive prenatal testing and its effect on target populations
by: Shaozhe Yang, et al.
Published: (2025-01-01) -
Performance of cell free DNA as a screening tool based on the results of first trimester screening
by: Mahtab Motevasselian, et al.
Published: (2024-12-01) -
Controversies in implementing non‐invasive prenatal testing in a public antenatal care program
by: Kjell Åsmund Blix Salvesen, et al.
Published: (2022-06-01)